Bio-Techne
TECH
565 hedge funds and large institutions have $17.8B invested in Bio-Techne in 2021 Q3 according to their latest regulatory filings, with 93 funds opening new positions, 201 increasing their positions, 177 reducing their positions, and 34 closing their positions.
174% more first-time investments, than exits
New positions opened: 93 | Existing positions closed: 34
23% more funds holding in top 10
Funds holding in top 10: 13 → 16 (+3)
14% more repeat investments, than reductions
Existing positions increased: 201 | Existing positions reduced: 177
11% more funds holding
Funds holding: 511 → 565 (+54)
8% more capital invested
Capital invested by funds: $16.4B → $17.8B (+$1.36B)
1.72% less ownership
Funds ownership: 376.51% → 374.79% (-1.7%)
17% less call options, than puts
Call options by funds: $36.3M | Put options by funds: $43.8M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$308M |
| 2 |
State Street
Boston,
Massachusetts
|
+$155M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$84.2M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$74.4M |
| 5 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
+$67M |
Top Sellers
| 1 |
BlackRock
New York
|
-$427M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$88.6M |
| 3 |
JSP
Jackson Square Partners
Larkspur,
California
|
-$63M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$59.2M |
| 5 |
GCM
Geneva Capital Management
Milwaukee,
Wisconsin
|
-$43.2M |
TECH Hedge Fund Activity: Q3 2021 in Review
565 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q3 2021, worth a combined $17.8B — up 8.3% from $16.4B a quarter earlier.
Buyers outnumbered sellers: 93 funds opened new TECH positions and 34 closed out — a net gain of 59 holders — while 201 added to existing stakes and 177 trimmed.
The largest buyer was Vanguard Group, adding an estimated $308M. The largest seller was BlackRock, cutting an estimated $427M.
- 565 institutional investors held Bio-Techne (TECH) as of Q3 2021, up from 511 in Q2 2021.
- Funds reported $17.8B of Bio-Techne stock for Q3 2021, up 8.3% quarter-over-quarter.
- 93 funds opened new Bio-Techne positions in Q3 2021 and 34 closed out, a net change of +59 holders.
- The largest Bio-Techne buyer in Q3 2021 was Vanguard Group, an estimated $308M added.
- The largest Bio-Techne seller in Q3 2021 was BlackRock, an estimated $427M sold.
Based on aggregated 13F filings for Q3 2021.